Vaccination coverage in Lebanon following the Syrian crisis: results from the district-based immunization coverage evaluation survey 2016.
Armed Conflicts
Caregivers
Child, Preschool
Cross-Sectional Studies
Ethnicity
Female
Humans
Immunization
Immunization Programs
Infant
Lebanon
Male
Patient Dropouts
Poliomyelitis
Poliovirus Vaccines
/ administration & dosage
Refugees
Rotavirus Vaccines
/ administration & dosage
Surveys and Questionnaires
Syria
Vaccination
/ statistics & numerical data
Vaccination Coverage
Vaccines
/ administration & dosage
Vaccines, Attenuated
/ administration & dosage
Coverage evaluation survey
Expanded Programme on immunization
Lebanon
Syrian refugees
Vaccination coverage
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
14 Jan 2019
14 Jan 2019
Historique:
received:
30
07
2018
accepted:
09
01
2019
entrez:
16
1
2019
pubmed:
16
1
2019
medline:
20
2
2019
Statut:
epublish
Résumé
Following the Syrian crisis, a substantial influx of Syrian refugees into Lebanon posed new challenges to optimal vaccination coverage for all children residing in the country. In 2016, the district-based immunization coverage evaluation survey (CES) assessed routine immunization coverage at the district level in Lebanon among children aged 12-59 months. A cross-sectional multistage cluster survey was conducted in all of Lebanon (with the exception of the Nabatieh district) using the World Health Organization (WHO) recommended Expanded Programme on Immunization (EPI) methodology adapted to the local context. A survey questionnaire consisting of closed and open-ended questions concerning demographic information and the child's immunization status was administered to collect immunization status information. Among surveyed children aged 12-59 months, irrespective of nationality, vaccination coverage at the national level for any recommended last dose was below the targeted 95%. Generally, vaccination coverage levels increased with age and were higher among Lebanese than Syrian children. However, large variations were revealed when coverage rates were analyzed at the district level. Vaccination was significantly associated with nationality, age, mother's educational status and the place of vaccination. Common reasons for undervaccination included the child's illness at the time of vaccine administration, vaccination fees, lack of awareness or a doctor's advice not to vaccinate during campaigns. Substantial variability exists in vaccination coverage among children aged 12-59 months residing in different districts in Lebanon. Immunization coverage reached 90% or above only for the first doses of polio and pentavalent vaccines. A considerable dropout rate from the first dose of any vaccine is observed. Efforts to optimize coverage levels should include increased vaccination initiatives targeting both refugee children and children from vulnerable host communities, increased cooperation between public and private vaccine providers, improved training for vaccine providers to adhere to complete vaccine administration recommendations, and increased awareness among caregivers.
Sections du résumé
BACKGROUND
BACKGROUND
Following the Syrian crisis, a substantial influx of Syrian refugees into Lebanon posed new challenges to optimal vaccination coverage for all children residing in the country. In 2016, the district-based immunization coverage evaluation survey (CES) assessed routine immunization coverage at the district level in Lebanon among children aged 12-59 months.
METHODS
METHODS
A cross-sectional multistage cluster survey was conducted in all of Lebanon (with the exception of the Nabatieh district) using the World Health Organization (WHO) recommended Expanded Programme on Immunization (EPI) methodology adapted to the local context. A survey questionnaire consisting of closed and open-ended questions concerning demographic information and the child's immunization status was administered to collect immunization status information.
RESULTS
RESULTS
Among surveyed children aged 12-59 months, irrespective of nationality, vaccination coverage at the national level for any recommended last dose was below the targeted 95%. Generally, vaccination coverage levels increased with age and were higher among Lebanese than Syrian children. However, large variations were revealed when coverage rates were analyzed at the district level. Vaccination was significantly associated with nationality, age, mother's educational status and the place of vaccination. Common reasons for undervaccination included the child's illness at the time of vaccine administration, vaccination fees, lack of awareness or a doctor's advice not to vaccinate during campaigns.
CONCLUSIONS
CONCLUSIONS
Substantial variability exists in vaccination coverage among children aged 12-59 months residing in different districts in Lebanon. Immunization coverage reached 90% or above only for the first doses of polio and pentavalent vaccines. A considerable dropout rate from the first dose of any vaccine is observed. Efforts to optimize coverage levels should include increased vaccination initiatives targeting both refugee children and children from vulnerable host communities, increased cooperation between public and private vaccine providers, improved training for vaccine providers to adhere to complete vaccine administration recommendations, and increased awareness among caregivers.
Identifiants
pubmed: 30642314
doi: 10.1186/s12889-019-6418-9
pii: 10.1186/s12889-019-6418-9
pmc: PMC6332691
doi:
Substances chimiques
Poliovirus Vaccines
0
RotaTeq
0
Rotavirus Vaccines
0
Vaccines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Bill and Melinda Gates Foundation
ID : Not applicable
Références
Vaccine. 2011 Oct 26;29(46):8215-21
pubmed: 21893149
Vaccine. 2013 Mar 15;31(12):1560-8
pubmed: 23196207
PLoS Pathog. 2014 Nov 13;10(10):e1004438
pubmed: 25393545
Vaccine. 2014 Dec 5;32(51):6870-6879
pubmed: 25444813
PLoS One. 2016 Mar 02;11(3):e0149970
pubmed: 26934372
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
PLoS One. 2016 Dec 19;11(12):e0168145
pubmed: 27992470
J Glob Health. 2016 Dec;6(2):020704
pubmed: 28154758
Wkly Epidemiol Rec. ;92(17):205-27
pubmed: 28459148